Announce Date | 05/01/2025 |
EPS Normalized Actual | $2.57 (Beat by $0.17) |
EPS GAAP Actual | $2.57 (Beat by $0.17) |
Revenue Actual | $1.16675B |
Revenue Surprise | Beat by $1166.75M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.7275 |
EPS GAAP Estimate | $2.7275 |
Revenue Estimate | $1.24078825B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Jun 2028 | 12.11 | 21.54 | 11.90941 | 12.30169 | 1 |
Jun 2027 | 11.2 | 23.29 | 11.04215 | 11.35763 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.6 | 0.0033300000000001 | 1.16675B | 1.75% | -11.93M |
FQ4 2024 (Dec 2024) | 2.43 | -0.0175 | 1.073B | 100% | -75.35M |
FQ3 2024 (Sep 2024) | 2.4 | 0.85859 | 1.09894B | 0.34% | -1091.44M |
FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 1.16067B | 0.22% | 1160.67M |
FQ1 2024 (Mar 2024) | 2.51 | 2.51 | 1.14639B | 1.25% | 1146.39M |
FQ4 2023 (Dec 2023) | 0 | 0 | 0B | -INF% | 0M |
FQ3 2023 (Sep 2023) | 2.42 | 2.42 | 1.09519B | 2.99% | 1095.19M |
FQ2 2023 (Jun 2023) | 2.39 | 2.39 | 1.15807B | 8.34% | 1158.07M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.7275
Consensus Revenue Estimates
1.24078825B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 3.2 | -- | 3.13402 | 3.35336 | 3 |
FQ4 2026 (Dec 2026) | 2.85 | -- | 2.79123 | 2.98658 | 3 |
FQ3 2026 (Sep 2026) | 2.75 | -- | 2.69329 | 2.88179 | 3 |
FQ1 2026 (Mar 2026) | 2.575 | -0.97 | 2.41835 | 2.67845 | 3 |
FQ4 2025 (Dec 2025) | 2.345 | -3.62 | 2.20235 | 2.43921 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 1.35B | -- | 1.33B | 1.4B | 4 |
FQ4 2026 (Dec 2026) | 1.33B | -- | 1.3B | 1.37B | 4 |
FQ3 2026 (Sep 2026) | 1.3B | -- | 1.28B | 1.35B | 4 |
FQ1 2026 (Mar 2026) | 1.22B | 4.05 | 1.16B | 1.25B | 4 |
FQ4 2025 (Dec 2025) | 1.11B | 3.43 | 1.06B | 1.15B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
4
Revenue # of Misses
3
Revenue # of in-lines
1
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 2.59667 | 2.6 | 0.0033300000000001 | 0.13% |
FQ4 2024 (Dec 2024) | 2.4475 | 2.43 | -0.0175 | -0.72% |
FQ3 2024 (Sep 2024) | 1.54141 | 2.4 | 0.85859 | 35.77% |
FQ2 2024 (Jun 2024) | 2.68 | 2.68 | 100% | |
FQ1 2024 (Mar 2024) | 2.51 | 2.51 | 100% | |
FQ4 2023 (Dec 2023) | 0 | 0 | NAN% | |
FQ3 2023 (Sep 2023) | 2.42 | 2.42 | 100% | |
FQ2 2023 (Jun 2023) | 2.39 | 2.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $1.18B | $1.17B | $-11.93M | -1.02% |
FQ4 2024 (Dec 2024) | $1.15B | $1.07B | $-75.35M | -7.02% |
FQ3 2024 (Sep 2024) | $2.19B | $1.1B | $-1091.44M | -99.32% |
FQ2 2024 (Jun 2024) | $0B | $1.16B | $1160.67M | 100% |
FQ1 2024 (Mar 2024) | $0B | $1.15B | $1146.39M | 100% |
FQ4 2023 (Dec 2023) | $0B | $0B | $0M | NAN% |
FQ3 2023 (Sep 2023) | $0B | $1.1B | $1095.19M | 100% |
FQ2 2023 (Jun 2023) | $0B | $1.16B | $1158.07M | 100% |